FDA Authorizes J&J Covid-19 Shot, Adding Millions of Doses to Total Vaccine Supply
Yet another vaccine is now part of our arsenal of weapons against the covid-19 pandemic. On Saturday, the Food and Drug Administration granted an emergency use authorization (EUA) to the one-dose shot developed by Johnson & Johnson. It joins the two-dose mRNA vaccines developed by Moderna and Pfizer/BioNTech.